Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
The return on assets (ROA) is -49.10% as of the fiscal period ended Wednesday, December 31, 2025.
Reported quarterly return on assets; no daily interpolation.
Limited quarterly history available
ROA needs at least three reported quarters before a meaningful chart is shown.
RETURN ON ASSETS (ROA)
-49.10%
RETURN ON ASSETS (ROA) AVG TTM
N/A
RETURN ON ASSETS (ROA) AVG 3Y
N/A
RETURN ON ASSETS (ROA) AVG 5Y
N/A
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-30.70%
median of 715 covered companies
CURRENT VS SECTOR MEDIAN
-59.93%
vs the sector median at left
Market Cap
$1.24B
Return on Assets (ROA)
-34.68%
TTM Avg
-39.07%
3Y Avg
-38.32%
5Y Avg
-34.05%
Market Cap
$1.23B
Return on Assets (ROA)
1.31%
TTM Avg
-17.71%
3Y Avg
-26.67%
5Y Avg
-26.67%
Market Cap
$1.23B
Return on Assets (ROA)
5.91%
TTM Avg
1.36%
3Y Avg
-4.42%
5Y Avg
-8.30%
Market Cap
$1.22B
Return on Assets (ROA)
-5.96%
TTM Avg
3.87%
3Y Avg
-6.09%
5Y Avg
-17.05%
Market Cap
$1.22B
Return on Assets (ROA)
-0.46%
TTM Avg
-2.95%
3Y Avg
-4.25%
5Y Avg
-4.39%
Market Cap
$1.32B
Return on Assets (ROA)
-68.96%
TTM Avg
-38.41%
3Y Avg
-33.02%
5Y Avg
-35.57%
Market Cap
$1.35B
Return on Assets (ROA)
43.52%
TTM Avg
-28.82%
3Y Avg
-20.19%
5Y Avg
-30.60%
Market Cap
$1.17B
Return on Assets (ROA)
-48.35%
TTM Avg
-102.84%
3Y Avg
-97.55%
5Y Avg
-75.48%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kardigan, Inc. (KARD) | $1.27B | -49.10% | N/A | N/A | N/A |
| ORIC Pharmaceuticals, Inc. (ORIC)vs › | $1.24B | -34.68% | -39.07% | -38.32% | -34.05% |
| Omada Health (OMDA)vs › | $1.23B | 1.31% | -17.71% | -26.67% | -26.67% |
| Cronos Group Inc. (CRON)vs › | $1.23B | 5.91% | 1.36% | -4.42% | -8.30% |
| MannKind Corporation (MNKD)vs › | $1.22B | -5.96% | 3.87% | -6.09% | -17.05% |
| Innovage Holding Corp. (INNV)vs › | $1.22B | -0.46% | -2.95% | -4.25% | -4.39% |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.32B | -68.96% | -38.41% | -33.02% | -35.57% |
| Omeros Corporation (OMER)vs › | $1.35B | 43.52% | -28.82% | -20.19% | -30.60% |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.17B | -48.35% | -102.84% | -97.55% | -75.48% |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.37B | -32.81% | -32.81% | -32.81% | -32.81% |
ROA
-49.1%
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -49.10% |
